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Pregnancy Induced Microangiopathy, HELLP or TTP!
Ahmed Amro, MD1, Alaa Gabi, MD2, and Zeid J. Khitan, MD1

ABSTRACT
I ntroduction: Thrombotic thrombocytopenic purpura (TTP) in pregnancy is rare and can
be fatal if misdiagnosed. Typically patients present with microangiopathic hemolytic
anemia, thrombocytopenia, altered mental status, fever, and renal abnormalities
Case Description: We are presenting a case of 26 year old pregnant female presented
with elevated BP. She had scattered Bruises in her legs, thighs and arms along with +2
bilateral pitting leg edema. Initial and subsequent laboratory studies showed features
of microangiopathic hemolytic anemia (MAHA), which brought up the suspicion of
HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome initially. Labor
was induced after transfusion of 2 units of PRBCs and 2 units of Platelets. The patient
platelets and hemoglobin showed no improvement after delivery and she continued to
have hemolysis despite delivery and steroids administration. Daily therapeutic plasma
exchange was initiated as the index of suspicion for TTP increased. After two sessions,
there was a significant improvement in the platelet count and hemolysis profile which
were normalized by the 4th session.
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Conclusion: Congenital TTP is a rare syndrome that clinicians should be aware of. Early
initiation of plasma exchange dramatically improves survival from less than 10% to
approximately 80%. This can only be achieved by having high level of suspicion and
awareness to this possibility.
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INTRODUCTION

CASE PRESENTATION

Thrombotic thrombocytopenic purpura (TTP) in
pregnancy is rare and can be fatal if misdiagnosed.1
Hereditary or acquired TTP must be considered in
the differential diagnosis of pregnancy-induced
microangiopathic hemolytic anemia (MAHA) along
with severe preeclampsia as in hemolysis, elevated
liver enzymes, low platelets (HELLP) syndrome.2
In TTP, early initiation of plasma exchange
dramatically improves survival from less than 10% to
approximately 80%.1

A 26 year old Caucasian female presented for a
routine peripartum visit. She was G1P0 at 35 weeks
gestation. Her pre-partum history was significant
for mild bruising tendency since childhood and
subnephrotic proteinuria.
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She was found to have elevated blood pressure of
140/90 and had 13 lbs. weight gain over a two week
period. She reported increasing swelling in her legs
and face one week prior to presentation. She denied
headaches, blurry vision, right upper quadrant
pain, dyspnea, nausea, or vomiting. Other than
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hypertension, physical exam showed vital signs of HR
88 RR 18 and Temp of 98. Abdomen was soft, gravid,
and non-tender. She had scattered bruises in her legs,
thighs and arms along with +2 bilateral pitting leg
edema. Initial and subsequent laboratory studies are
shown in the table.
The combination of high blood pressure, proteinuria,
hemolytic anemia and thrombocytopenia brought up
the suspicion of HELLP syndrome. Labor was induced
after transfusion of 2 units of PRBCs and 2 units of
platelets. The mother and her newborn were closely
observed on labor and delivery unit. The fetal heart
TABLE: The patient laboratory work up

rate showed no major abnormalities. Apgar score
was 3 & 8 at 1 & 5 minutes respectively. The patient
platelets and hemoglobin showed no improvement
and she continued to have hemolysis despite
delivery and steroids administration. At this point,
daily therapeutic plasma exchange was initiated as
the index of suspicion for TTP increased. After two
sessions, there was a significant improvement in
the platelet count and hemolysis profile which were
normalized by the 4th session.
DISCUSSION
TTP (Moschcowitz syndrome) is an acute, rare,
and potentially fatal disorder.3 The
classical pentad of clinical features
includes microangiopathic hemolytic
anemia, thrombocytopenia,
neurologic symptoms, fever, and
renal abnormalities.4 It is caused
by absent or severely depleted
ADAMTS-13, the von Willebrand
factor (VWF) cleaving protease.3 It
is either acquired, likely immune
mediated, or hereditary, also called
Upshaw-Schulman syndrome.5
Upshaw-Schulman syndrome or
Congenital TTP (cTTP) is caused
by homozygous or compound
heterozygous ADAMTS13
mutations.6-7 It is diagnosed by
the documentation of a severe
deficiency in ADAMTS13 activity
(<10%), and absence of ADAMTS13
autoantibody. The diagnosis is
confirmed by documentation
of ADAMTS13 mutation.8 cTTP
clinical signs may be mild or absent
during childhood. History of easy
bruising during childhood due to
isolated thrombocytopenia can be
the only symptom.9 There are two
age clusters for the initial episode
of cTTP; about half of patients
have their first acute episode in
infancy or early childhood, while
the other half remain asymptomatic
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until adulthood,9 with pregnancy being the most
important precipitant of initial acute episode.7
Physiologic changes during pregnancy including
progressive increase of VWF and associated
decrease of ADAMTS13 can be considered a likely
triggering mechanism for the acute episodes of
TTP.5 Pregnancy induced cTTP mostly occurs in the
third trimester,3,9 which is likely related to the period
over which the level of VWF is increased during
pregnancy.5,9
On the other hand, preeclampsia/HELLP syndrome
can be associated with thrombocytopenia,
microangiopathic hemolytic anemia, neurologic
symptoms, and renal insufficiency, making
their distinction from TTP difficult or impossible
especially since their onset can be delayed to the
third trimester of pregnancy as in TTP.3,9 There
are some features that may favor the diagnosis of
TTP over HELLP syndrome which include severe
thrombocytopenia (less the 20,000) and an elevated
LDH-to-AST ratio.3 ADAMTS-13 activity might be
reduced along with elevated VWF levels in HELLP
syndrome, but a severe reduction in ADAMTS-13
activity (<10%)10 along with an increase in ultra
large VWF multimers is usually suggestive of TTP.3
On the other hand HELLP syndrome is usually
associated with preeclampsia, so hypertension
and proteinuria would favor a diagnosis of HELLP
syndrome.
The probability of serious maternal and fetal
complications during pregnancy is high in patients
with cTTP.5 Untreated TTP is associated with a > 90%
mortality.1 Without appropriate treatment, the risk
of recurrent episode in patients with cTTP during
the next pregnancy is almost 100%.5 Daily plasma
exchange and glucocorticoids is the main therapy
for adult patients with TTP during pregnancy,4
which dramatically improved survival from less
than 10% to approximately 80%.1,3 Patients with
cTTP respond quickly to plasma transfusion either
upon need or intermittently every 2-3 weeks as a
prophylactic therapy. Some plasma derived factor
VIII/VWF concentrates contain sufficient amount of
ADAMTS13 that was found to be useful in treating
cTTP, replacing FFP and plasma exchange.11
CONCLUSION
Congenital TTP is a rare syndrome that clinicians
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should be aware of. It can be misdiagnosed in
pregnancy as HELLP syndrome, which is more
common in this group of patients. If untreated, death
from disseminated microvascular thrombosis occurs
which makes early detection and treatment of this
disease life saving. This can only be achieved by
having high level of suspicion and awareness to this
possibility.
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